SecBot SecBot
8-K ·Filed Nov 5, 2026

GEHC

GE HealthCare Technologies Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed11d 17h ago SEC0001932393-26-000063
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for the naming of a successor and any strategic changes in the R&D or technology roadmap. The resignation of the top science officer without a stated reason or replacement introduces some uncertainty but is not a red flag on its own.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$83.75
T+0 close · Nov 5, 2026 · via day close
Latest settled
−2.28%
T+5 · $81.84
Vs SPY
−5.57%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $83.75entry
  2. T+1 · 11d ago −1.64%α −1.95% · $82.38
  3. T+5 · 5d ago −2.28%α −5.57% · $81.84
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

GE HealthCare's Chief Science and Technology Officer Taha Kass-Hout notified the company of his resignation effective December 31, 2026. No replacement has been named, and the filing provides no reason for the departure.

Key Facts

  • Taha Kass-Hout notified GE HealthCare of his resignation as Chief Science and Technology Officer on November 4, 2026
  • His last day will be December 31, 2026
  • No replacement has been named in the filing
  • The filing does not state a reason for the departure

Financial Impact

No financial impact stated; departure of a senior technology officer with no immediate replacement

Risk Factors

  • No successor named creates a leadership gap in the science and technology function
  • Lack of stated reason for departure could signal internal issues, though no evidence of that in the filing

Market Snapshot

Exchange
Nasdaq
Sector
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Analyst Consensus
72% bullish (29 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001932393-26-000063
Document: 0001932393-26-000063-index-headers.html0001932393-26-000063
Document: 0001932393-26-000063-index.html0001932393-26-000063
Document: 0001932393-26-000063.txt0001932393-26-000063

Track record

13 reports on GEHC

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +19.07% at T+20 after the Oct 19, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Neutral 3/10 Viewing Entry $83.75 to $81.84 Now $82.96 −0.94% ▼ −2.28% −5.57% vs SPY
  2. Nov 4, 202612d ago 144 Neutral 2/10 Entry $83.75 to $81.84 Now $82.96 −0.94% ▼ −2.28% −5.57% vs SPY
  3. Oct 28, 202619d ago 8-K Bullish 6/10 Entry $75.82 to $85.81 Now $82.96 +9.42% ▲ +13.18% +13.89% vs SPY
  4. Oct 19, 202628d ago Institutional Cluster Bullish 4/10 Entry $69.72 to $71.60 Now $82.96 +18.99% ▲ +2.70% +2.84% vs SPY
  5. Sep 22, 20267w ago 8-K Neutral 2/10 Entry $66.09 to $65.37 Now $82.96 +25.53% ▼ −1.09% −0.41% vs SPY
  6. Sep 16, 20268w ago 3 Neutral 2/10 Entry $64.45 to $66.38 Now $82.96 +28.73% ▲ +3.00% +2.40% vs SPY
  7. Jul 29, 202615w ago 8-K Neutral 2/10 Entry $71.90 to $70.24 Now $82.96 +15.38% ▼ −2.31% −7.84% vs SPY
  8. May 13, 202626w ago Insider Cluster Neutral 2/10 Entry $64.26 to $62.86 Now $82.96 +29.10% ▼ −2.18% −3.98% vs SPY
  9. May 11, 202627w ago 8-K Neutral 2/10 Entry $62.29 to $61.51 Now $82.96 +33.18% ▼ −1.25% −1.33% vs SPY
  10. Apr 30, 202628w ago Insider Cluster Neutral 4/10 Entry $60.96 to $63.40 Now $82.96 +36.09% ▲ +4.00% +1.64% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 6h 54m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026